Trial Profile
Remission Phase Study with MD-0901 -Phase 3 Clinical Trial in Patients with Ulcerative Colitis in Remission Phase
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Mesalazine (Primary)
- Indications Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 03 Jun 2016 New trial record